<DOC>
	<DOCNO>NCT00010153</DOCNO>
	<brief_summary>RATIONALE : Estrogen stimulate growth breast cancer cell . Hormone therapy use ICI 182780 surgery may block uptake estrogen tumor cell prevent metastasis . It yet know ICI 182780 effective prevent breast cancer metastasis . PURPOSE : Randomized phase III trial study effectiveness ICI 182780 give surgery treat woman stage I stage II primary breast cancer .</brief_summary>
	<brief_title>ICI 182780 Treating Women With Stage I Stage II Primary Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine inhibitory effect ICI 182780 development metastasis , measure disease-free survival overall survival , woman operable stage I II primary breast cancer . - Determine toxicity regimen patient . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients stratify accord participate center menopausal status ( premenopausal v postmenopausal ) . Patients randomize receive either ICI 182780 IM placebo IM 2 minute day 1 . Patients undergo surgery day 8 29 . Patients follow every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A total 3,656 patient ( 1,828 per arm ) accrue study within 2 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fulvestrant</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm stage I II primary operable breast cancer Surgery plan within next 14 week Hormone receptor status : Estrogen receptor positive unknown No known estrogen receptor negative tumor Unknown progesterone receptor status eligible PATIENT CHARACTERISTICS : Age : Any age Sex : Female Menopausal status : Premenopausal postmenopausal Performance status : Not specify Life expectancy : Not specify Hematopoietic : No bleed diathesis compatible IM depot injection Hepatic : Not specify Renal : Not specify Other : Not pregnant Negative pregnancy test Fertile patient must use effective nonhormonal contraception 23 month study No prior concurrent malignancy except adequately treat basal cell carcinoma skin cancer uterine cervix No psychological , familial , sociological , geographical condition would preclude study PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : At least 2 month since prior ICI 182780 Radiotherapy : No prior radiotherapy primary tumor Surgery : See Disease Characteristics Other : No concurrent preoperative therapy breast cancer</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
</DOC>